DIN 00343617 — ROFACT 300 MG
ROFACT is a capsule of Rifampin marketed by BAUSCH HEALTH, CANADA INC.. The full Rifampin monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 00343617
- Brand name
- ROFACT
- Active ingredient
- Rifampin
- Strength
- 300 MG
- Dosage form
- CAPSULE
- Route
- ORAL
- Manufacturer
- BAUSCH HEALTH, CANADA INC.
- Health Canada status
- MARKETED
- Drug class
- Rifamycin antibiotic (antituberculosis agent)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Rifampin products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 00393444 | ROFACT | 150 MG | CAPSULE | BAUSCH HEALTH, CANADA INC. | MARKETED |